Obsidio Obsidio is a company that develops universal immobilization biomaterial products designed to restore health and extending life by stopping undesirable flow in vessels anywhere in the body. | ![]() Monarch Biosciences Monarch Biosciences is a company that develops a pipeline of products based on its proprietary thin-film nitinol (TFN) biomaterial. | ![]() WaveFront Dynamics WaveFront Dynamics is a company that develops a wavefront diagnostic technology intended to assess the visual performance of the human eye. | ![]() Asthmatuner Asthmatuner is a company that develops an asthma application intended to provide treatment recommendations to asthma patients. | ||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 2014 | Founding Date 2019 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations HQ | Locations Newton, US HQ | Locations Albuquerque, US HQ | Locations Stockholm, SE HQ |
Employees | Employees 3 | Employees N/A | Employees N/A | Employees 14 | Employees 23 |
Funding | |||||
Latest funding round | Latest funding round $ 225k (over 5 years ago) | Latest funding round $ 1m (about 6 years ago) | Latest funding round $ 43.9m (almost 6 years ago) | Latest funding round $ 3m (over 5 years ago) | Latest funding round $ 1.5m (about 6 years ago) |
Total funding raised | Total funding raised $ 3.2m | Total funding raised $ 1m | Total funding raised $ 43.9m | Total funding raised $ 3m | Total funding raised $ 1.5m |

Monarch Biosciences is a company that develops a pipeline of products based on its proprietary thin-film nitinol (TFN) biomaterial.
View company
CereVasc is a company focused on improving the treatment of patients with hydrocephalus.
View company
WaveFront Dynamics is a company that develops a wavefront diagnostic technology intended to assess the visual performance of the human eye.
View company
Asthmatuner is a company that develops an asthma application intended to provide treatment recommendations to asthma patients.
View company